Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-28T09:42:35.142Z Has data issue: false hasContentIssue false
  • English
  • Français

Response to Prior and Fitzpatrick

Published online by Cambridge University Press:  19 February 2016

Sirisha Kundrapu ,
Venkata Sunkesula ,
Myreen Tomas  and
Curtis J. Donskey
Sirisha Kundrapu
Affiliation:
Department of Medicine, Infectious Diseases Division, Case Western Reserve University School of Medicine, Cleveland, Ohio
Venkata Sunkesula
Affiliation:
Department of Medicine, Infectious Diseases Division, Case Western Reserve University School of Medicine, Cleveland, Ohio
Myreen Tomas
Affiliation:
Department of Medicine, Infectious Diseases Division, Case Western Reserve University School of Medicine, Cleveland, Ohio Geriatric Research, Education, and Clinical Center, Cleveland Veterans Affairs Medical Center, Cleveland, Ohio.
Curtis J. Donskey*
Affiliation:
Department of Medicine, Infectious Diseases Division, Case Western Reserve University School of Medicine, Cleveland, Ohio Geriatric Research, Education, and Clinical Center, Cleveland Veterans Affairs Medical Center, Cleveland, Ohio.
*
Address correspondence to Curtis J. Donskey, MD, Geriatric Research, Education, and Clinical Center, Cleveland Veterans Affairs Medical Center, 10701 East Boulevard, Cleveland, Ohio 44106 ([email protected]).
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 37 , Issue 3 , March 2016 , pp. 362 - 363
Copyright
© 2016 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Kundrapu, S, Sunkesula, V, Tomas, M, Donskey, CJ. Skin and environmental contamination in patients diagnosed with Clostridium difficile infection but not meeting clinical criteria for testing. Infect Control Hosp Epidemiol 2015;36:1348–1350.CrossRefGoogle Scholar
2. Koo, HL, Van, JN, Zhao, M, et al. Real-time polymerase chain reaction detection of asymptomatic Clostridium difficile colonization and rising C. difficile-associated disease rates. Infect Control Hosp Epidemiol 2014;35:667–673.Google Scholar
3. Polage, CR, Gyorke, CE, Kennedy, MA, et al. Overdiagnosis of Clostridium difficile infection in the molecular test era. JAMA Intern Med 2015;175:1792–1801.Google Scholar
4. Buckel, WR, Avdic, E, Carroll, KC, Gunaseelan, V, Hadhazy, E, Cosgrove, SE. Gut check: Clostridium difficile testing and treatment in the molecular testing era. Infect Control Hosp Epidemiol 2015;36:217–221.CrossRefGoogle ScholarPubMed
5. Peterson, LR, Robicsek, A. Does my patient have Clostridium difficile infection? Ann Intern Med 2009;151:176–179.CrossRefGoogle ScholarPubMed
6. Planche, T, Wilcox, MH. Diagnostic pitfalls in Clostridium difficile infection. Infect Dis Clin North Am 2015;29:63–82.Google Scholar
7. Prior, AR, Fitzpatrick, F. Clostridium difficile—To Test or Not to Test? Response to Kundrapu et al. Infect Control Hosp Epidemiol 2016;37:361–362.Google Scholar
8. Biswas, JS, Patel, A, Otter, JA, van Kleef, E, Goldenberg, SD. Contamination of the hospital environment from potential Clostridium difficile excretors without active infection. Infect Control Hosp Epidemiol 2015;36:975–977.Google Scholar
9. Kyne, L, Warny, M, Qamar, A, et al. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000;342:390–397.CrossRefGoogle ScholarPubMed
10. Louie, TJ, Cannon, K, Byrne, B, et al. Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI. Clin Infect Dis 2012;55(Suppl 2):S132–S142.CrossRefGoogle ScholarPubMed
11. Donskey, CJ, Kundrapu, S, Deshpande, A. Colonization versus carriage of Clostridium difficile . Infect Dis Clin North Am 2015;29:13–28.Google Scholar